(EFV) MSCI EAFE Value - Overview
Etf: Stocks, International, Developed, Value, Diversified
Dividends
| Dividend Yield | 4.46% |
| Yield on Cost 5y | 7.50% |
| Yield CAGR 5y | 9.70% |
| Payout Consistency | 91.2% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 14.3% |
| Relative Tail Risk | 3.65% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.18 |
| Alpha | 35.59 |
| Character TTM | |
|---|---|
| Beta | 0.584 |
| Beta Downside | 0.581 |
| Drawdowns 3y | |
|---|---|
| Max DD | 13.72% |
| CAGR/Max DD | 1.61 |
Description: EFV MSCI EAFE Value December 17, 2025
The iShares MSCI EAFE Value ETF (BATS: EFV) seeks to track a subset of the MSCI EAFE Index that emphasizes value-styled large-cap stocks from Europe, Australasia, and the Far East. At least 80 % of the fund’s assets are invested in the index’s component securities or in securities that are economically equivalent, ensuring tight alignment with the underlying benchmark.
Key metrics (as of Q3 2024) include an expense ratio of 0.15 % and assets under management of roughly $5 billion. The top sector exposures are Financials (≈ 25 % of assets), Consumer Staples (≈ 20 %) and Health Care (≈ 15 %). Major holdings feature multinational value leaders such as Nestlé, Roche, and HSBC. Performance is closely tied to Euro-zone growth, Yen movements, and commodity price trends that affect Australian exporters.
For a deeper quantitative comparison, you might explore ValueRay’s toolkit to see how EFV stacks up against other global value ETFs.
What is the price of EFV shares?
Over the past week, the price has changed by +3.32%, over one month by +7.51%, over three months by +15.88% and over the past year by +45.41%.
Is EFV a buy, sell or hold?
What are the forecasts/targets for the EFV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 99.9 | 28.4% |
EFV Fundamental Data Overview February 07, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 28.74b USD (28.74b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 28.74b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 28.74b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.07% (E(28.74b)/V(28.74b) * Re(8.07%) + (debt-free company))
Discount Rate = 8.07% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)